Somatic-type malignancy in germ cell tumors

Nooshin K. Dashti, Rafael E Jimenez

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Somatic-type malignancies (STM) may occasionally develop in preexisting germ cell tumors (GCT). It is generally believed to result from transformation of teratomatous elements, although alternative mechanisms must exist, as not all STM develop in teratoma-containing GCT. The transformed histology includes sarcomas, carcinomas, primitive tumors, hematologic malignancies, and others. STM-GCT occurs across the spectrum of GCT, including type I, type II, type III, and type IV GCT, and in both gonadal and extragonadal sites. Derivation from the preexisting neoplastic germ cell has been supported by the presence of molecular signatures of GCT in the somatic component. The STM likely arises from the activation of oncogenes that normally play a role in the development of these tumors at their normal sites. Pathogenesis includes senescence of tissues in slow-growing, benign GCT or overgrowth of immature elements. The presence of STM renders worse outcome compared to conventional GCT without transformation. STM is generally resistant to chemotherapy targeted at GCT. Stage and feasibility of radical resection are the most important prognostic factors. The differential diagnosis of STM-GCT includes metastatic non-GCT-related malignancy, post-therapy changes, and other GCT elements.

Original languageEnglish (US)
Title of host publicationPathology and Biology of Human Germ Cell Tumors
PublisherSpringer Berlin Heidelberg
Pages419-439
Number of pages21
ISBN (Electronic)9783662537756
ISBN (Print)9783662537732
DOIs
StatePublished - Jan 1 2017

Fingerprint

Germ Cell and Embryonal Neoplasms
Neoplasms
Teratoma
Hematologic Neoplasms
Oncogenes
Germ Cells
Sarcoma
Histology
Differential Diagnosis
Carcinoma
Drug Therapy

Keywords

  • Malignant transformation
  • Non-germ cell histology
  • Somatic-type malignancy
  • Teratoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dashti, N. K., & Jimenez, R. E. (2017). Somatic-type malignancy in germ cell tumors. In Pathology and Biology of Human Germ Cell Tumors (pp. 419-439). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-53775-6_12

Somatic-type malignancy in germ cell tumors. / Dashti, Nooshin K.; Jimenez, Rafael E.

Pathology and Biology of Human Germ Cell Tumors. Springer Berlin Heidelberg, 2017. p. 419-439.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dashti, NK & Jimenez, RE 2017, Somatic-type malignancy in germ cell tumors. in Pathology and Biology of Human Germ Cell Tumors. Springer Berlin Heidelberg, pp. 419-439. https://doi.org/10.1007/978-3-662-53775-6_12
Dashti NK, Jimenez RE. Somatic-type malignancy in germ cell tumors. In Pathology and Biology of Human Germ Cell Tumors. Springer Berlin Heidelberg. 2017. p. 419-439 https://doi.org/10.1007/978-3-662-53775-6_12
Dashti, Nooshin K. ; Jimenez, Rafael E. / Somatic-type malignancy in germ cell tumors. Pathology and Biology of Human Germ Cell Tumors. Springer Berlin Heidelberg, 2017. pp. 419-439
@inbook{62e2033a0fc04c25ac2a811e3158ce09,
title = "Somatic-type malignancy in germ cell tumors",
abstract = "Somatic-type malignancies (STM) may occasionally develop in preexisting germ cell tumors (GCT). It is generally believed to result from transformation of teratomatous elements, although alternative mechanisms must exist, as not all STM develop in teratoma-containing GCT. The transformed histology includes sarcomas, carcinomas, primitive tumors, hematologic malignancies, and others. STM-GCT occurs across the spectrum of GCT, including type I, type II, type III, and type IV GCT, and in both gonadal and extragonadal sites. Derivation from the preexisting neoplastic germ cell has been supported by the presence of molecular signatures of GCT in the somatic component. The STM likely arises from the activation of oncogenes that normally play a role in the development of these tumors at their normal sites. Pathogenesis includes senescence of tissues in slow-growing, benign GCT or overgrowth of immature elements. The presence of STM renders worse outcome compared to conventional GCT without transformation. STM is generally resistant to chemotherapy targeted at GCT. Stage and feasibility of radical resection are the most important prognostic factors. The differential diagnosis of STM-GCT includes metastatic non-GCT-related malignancy, post-therapy changes, and other GCT elements.",
keywords = "Malignant transformation, Non-germ cell histology, Somatic-type malignancy, Teratoma",
author = "Dashti, {Nooshin K.} and Jimenez, {Rafael E}",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-3-662-53775-6_12",
language = "English (US)",
isbn = "9783662537732",
pages = "419--439",
booktitle = "Pathology and Biology of Human Germ Cell Tumors",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Somatic-type malignancy in germ cell tumors

AU - Dashti, Nooshin K.

AU - Jimenez, Rafael E

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Somatic-type malignancies (STM) may occasionally develop in preexisting germ cell tumors (GCT). It is generally believed to result from transformation of teratomatous elements, although alternative mechanisms must exist, as not all STM develop in teratoma-containing GCT. The transformed histology includes sarcomas, carcinomas, primitive tumors, hematologic malignancies, and others. STM-GCT occurs across the spectrum of GCT, including type I, type II, type III, and type IV GCT, and in both gonadal and extragonadal sites. Derivation from the preexisting neoplastic germ cell has been supported by the presence of molecular signatures of GCT in the somatic component. The STM likely arises from the activation of oncogenes that normally play a role in the development of these tumors at their normal sites. Pathogenesis includes senescence of tissues in slow-growing, benign GCT or overgrowth of immature elements. The presence of STM renders worse outcome compared to conventional GCT without transformation. STM is generally resistant to chemotherapy targeted at GCT. Stage and feasibility of radical resection are the most important prognostic factors. The differential diagnosis of STM-GCT includes metastatic non-GCT-related malignancy, post-therapy changes, and other GCT elements.

AB - Somatic-type malignancies (STM) may occasionally develop in preexisting germ cell tumors (GCT). It is generally believed to result from transformation of teratomatous elements, although alternative mechanisms must exist, as not all STM develop in teratoma-containing GCT. The transformed histology includes sarcomas, carcinomas, primitive tumors, hematologic malignancies, and others. STM-GCT occurs across the spectrum of GCT, including type I, type II, type III, and type IV GCT, and in both gonadal and extragonadal sites. Derivation from the preexisting neoplastic germ cell has been supported by the presence of molecular signatures of GCT in the somatic component. The STM likely arises from the activation of oncogenes that normally play a role in the development of these tumors at their normal sites. Pathogenesis includes senescence of tissues in slow-growing, benign GCT or overgrowth of immature elements. The presence of STM renders worse outcome compared to conventional GCT without transformation. STM is generally resistant to chemotherapy targeted at GCT. Stage and feasibility of radical resection are the most important prognostic factors. The differential diagnosis of STM-GCT includes metastatic non-GCT-related malignancy, post-therapy changes, and other GCT elements.

KW - Malignant transformation

KW - Non-germ cell histology

KW - Somatic-type malignancy

KW - Teratoma

UR - http://www.scopus.com/inward/record.url?scp=85034569398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034569398&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-53775-6_12

DO - 10.1007/978-3-662-53775-6_12

M3 - Chapter

AN - SCOPUS:85034569398

SN - 9783662537732

SP - 419

EP - 439

BT - Pathology and Biology of Human Germ Cell Tumors

PB - Springer Berlin Heidelberg

ER -